Drug
Pimodivir clinical trials
Also written JNJ-63623872 and VX-787.
How studies write it
Studies that test it under each name
Studies by the year they started
17 studies that test it; most in 2015 (6)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 6 |
| 2016 | 3 |
| 2018 | 3 |
| 2019 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 17 · Other 0
Janssen Research & Development, LLC (8) · Janssen-Cilag International NV (4) · Janssen Infectious Diseases BVBA (2) · Alios Biopharma Inc. (1) · Janssen Cilag N.V./S.A. (1) · Vertex Pharmaceuticals Incorporated (1)
Often tested with
Tested in the same studies.
Oseltamivir (3) · Sfericase (1) · Cyclosporine (1) · Ethinyl Estradiol (1) · Norethindrone (1) · Pitavastatin (1)
Studies
Open first, then newest update. How each study uses pimodivir is read from its arms, and is right about nine times in ten.
Testing it · 17
- Study of Acute Uncomplicated Seasonal Influenza A in Adult SubjectsCompletedPhase 2Janssen Research & Development, LLCNCT02342249Written as VX-787 300 mg
- A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing ComplicationsTerminatedPhase 3Janssen Research & Development, LLCNCT03381196Written as Pimodivir 600 mg
- A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A InfectionTerminatedPhase 3Janssen Research & Development, LLCNCT03376321Written as Pimodivir 600 mg
- A Study of Orally Administered Pimodivir in Adult Participants With Hepatic ImpairmentCompletedPhase 1Janssen-Cilag International NVNCT03816631Written as Pimodivir
- A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ-63623872CompletedPhase 1Alios Biopharma Inc.NCT02888327Written as JNJ-63623872
- A Study to Assess the Relative Oral Bioavailability of JNJ-63623872 Administered as Oral Concept Formulations Compared to the Current Tablet FormulationCompletedPhase 1Janssen Research & Development, LLCNCT02659735Written as JNJ-63623872 300 milligram (mg)
- A Study to Evaluate the Effect of JNJ-63623872 on Cardiac Repolarization Interval in Healthy ParticipantsCompletedPhase 1Janssen Research & Development, LLCNCT02658825Written as JNJ-63623872 2400 milligram (mg)
- A Study of Orally Administered Pimodivir in Adult Participants With Renal ImpairmentTerminatedPhase 1Janssen-Cilag International NVNCT03947814Written as Pimodivir
- A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A InfectionCompletedPhase 2Janssen Research & Development, LLCNCT02532283Written as JNJ-63623872
- A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy AdultsCompletedPhase 1Janssen-Cilag International NVNCT03768609Written as Pimodivir
- Safety, Tolerability, Pharmacokinetic and Absolute Bioavailability Study of JNJ-63623872 Administered as an Intravenous Infusion and a 600-Milligram (mg) Oral Dose in Healthy AdultsCompletedPhase 1Janssen-Cilag International NVNCT02860806Written as JNJ-63623872
- Study to Assess the Absorption, Metabolism and Excretion of 14C-JNJ-63623872 After a Single Dose in Healthy Male ParticipantsCompletedPhase 1Janssen Cilag N.V./S.A.NCT02448004Written as JNJ-63623872
- A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza VirusCompletedPhase 2Vertex Pharmaceuticals IncorporatedNCT01561807Written as VX-787
- A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and NorethindroneCompletedPhase 1Janssen Research & Development, LLCNCT02652650Written as JNJ-63623872
- A Study to Investigate the Effect of JNJ-63623872 on Pitavastatin in Healthy ParticipantsCompletedPhase 1Janssen Research & Development, LLCNCT02595268Written as JNJ-63623872
- A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ-63623872 in Healthy Japanese Adult ParticipantsCompletedPhase 1Janssen Infectious Diseases BVBANCT02418559Written as JNJ-63623872 (300 mg)
- A Study to Assess the Drug-Drug Interaction Between VX-787 and OseltamivirCompletedPhase 1Janssen Infectious Diseases BVBANCT02262715Written as VX-787
Given in every arm · 1 — pimodivir is usual care beside what is tested
Codes
What other systems call pimodivir · ClinicalTrials.gg INT000404
- MeSH (NLM) C000605010pimodivirOne source NLM
- UNII (FDA) DFC121MXC3PIMODIVIRConfirmed FDA, NLM, Wikidata
- Wikidata Q27276370pimodivirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C158086PimodivirOne source FDA
- DrugBank DB14974One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000605010 | pimodivir | One source NLM |
| UNII (FDA) | DFC121MXC3 | PIMODIVIR | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27276370 | pimodivir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C158086 | Pimodivir | One source FDA |
| DrugBank | DB14974 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.